相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent advances in biomaterial-boosted adoptive cell therapy
Yonger Xue et al.
CHEMICAL SOCIETY REVIEWS (2022)
Recent advances of biomaterials in stem cell therapies
Yonger Xue et al.
NANOTECHNOLOGY (2022)
CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
Zhongkun Zhang et al.
PHARMACEUTICS (2022)
Lipids as Regulators of Cellular Senescence
Shruthi Hamsanathan et al.
FRONTIERS IN PHYSIOLOGY (2022)
A Route to Lipid ALC-0315: a Key Component of a COVID-19 mRNA Vaccine
Fariba Saadati et al.
CHEMISTRY-A EUROPEAN JOURNAL (2022)
Lipid Nanoparticles for Drug Delivery
Letao Xu et al.
ADVANCED NANOBIOMED RESEARCH (2022)
Safe Nanoparticles: Are We There Yet?
Wided Najahi-Missaoui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma
Ting Wei et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Self-assembled mRNA vaccines
Jeonghwan Kim et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing
Shuai Liu et al.
NATURE MATERIALS (2021)
Targeting Innate Immunity in Cancer Therapy
Srikrishnan Rameshbabu et al.
VACCINES (2021)
A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod
Zhongkun Zhang et al.
PHARMACEUTICS (2021)
Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
Griffin Pauli et al.
PHARMACEUTICS (2021)
Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies
Bing-Mae Chen et al.
ACS NANO (2021)
Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Rumiana Tenchov et al.
ACS NANO (2021)
CpG-Based Nanovaccines for Cancer Immunotherapy
Wenqiang Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Nanoparticle-Mediated STING Agonist Delivery for Enhanced Cancer Immunotherapy
Qinghao Zhou et al.
MACROMOLECULAR BIOSCIENCE (2021)
Long Chain Fatty Acids as Modulators of Immune Cells Function: Contribution of FFA1 and FFA4 Receptors
Maria A. Hidalgo et al.
FRONTIERS IN PHYSIOLOGY (2021)
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Alexander J. Stephens et al.
FRONTIERS IN IMMUNOLOGY (2021)
Lipid nanoparticles for mRNA delivery
Xucheng Hou et al.
NATURE REVIEWS MATERIALS (2021)
Nanoplatforms for mRNA Therapeutics
Chaoyang Meng et al.
ADVANCED THERAPEUTICS (2021)
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Margaret M. Billingsley et al.
NANO LETTERS (2020)
A Synthetic Carrier of Nucleic Acids Structured as a Neutral Phospholipid Envelope Tightly Assembled on Polyplex Surface
Yonger Xue et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer
Parvin Zamani et al.
EUROPEAN JOURNAL OF CANCER (2020)
Liposomes as tunable platform to decipher the antitumor immune response triggered by TLR and NLR agonists
Celia Jacoberger-Foissac et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Itziar Gomez-Aguado et al.
NANOMATERIALS (2020)
A phase I study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral (iTu) injection alone and in combination with durvalumab.
Manish R. Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Nanoparticles versus Dendritic Cells as Vehicles to Deliver mRNA Encoding Multiple Epitopes for Immunotherapy
Rebuma Firdessa-Fite et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Lipid nanoparticles for nucleic acid delivery: Current perspectives
Eleni Samaridou et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway
Eui Ho Kim et al.
ELIFE (2020)
Efficient Colorectal Cancer Gene Therapy with IL-15 mRNA Nanoformulation
Sibei Lei et al.
MOLECULAR PHARMACEUTICS (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Gal Cafri et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
Maria L. Guevara et al.
FRONTIERS IN CHEMISTRY (2020)
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
Xinfu Zhang et al.
SCIENCE ADVANCES (2020)
Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy
Aaron J. Wilk et al.
BLOOD ADVANCES (2020)
A phase 1/2, open-label, multicenter, dose escalation and efficacy study of mRNA-2416, a lipid nanoparticle encapsulated mRNA encoding human OX40L, for intratumoral injection alone or in combination with durvalumab for patients with advanced malignancies
Antonio Jimeno et al.
CANCER RESEARCH (2020)
SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MRNA-4157 IN COMBINATION WITH PEMBROLIZUMAB IN SUBJECTS WITH UNRESECTABLE SOLID TUMORS (KEYNOTE-603): AN UPDATE
Julie Bauman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses
Carlos A. Arbelaez et al.
NPJ VACCINES (2020)
Adjuvant incorporated lipid nanoparticles for enhanced mRNA-mediated cancer immunotherapy
Kyuri Lee et al.
BIOMATERIALS SCIENCE (2020)
RIG-I-like receptors: their regulation and roles in RNA sensing
Jan Rehwinkel et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer
Bok Sil Hong et al.
CANCER RESEARCH (2019)
miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint
Duolu Li et al.
EXPERIMENTAL CELL RESEARCH (2019)
Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
Anthony Conway et al.
MOLECULAR THERAPY (2019)
Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles
Cory D. Sago et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2019)
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
Howard A. Burris et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
Kimberly J. Hassett et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
Beatriz Garcia-Pinel et al.
NANOMATERIALS (2019)
MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer
Parvin Zamani et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Immunomodulatory Nanosystems
Xiangru Feng et al.
ADVANCED SCIENCE (2019)
Lipid-based nanoparticle formulations for small molecules and RNA drugs
Ludger M. Ickenstein et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
Lei Miao et al.
NATURE BIOTECHNOLOGY (2019)
Targeted Delivery of siRNA Lipoplexes to Cancer Cells Using Macrophage Transient Horizontal Gene Transfer
Elizabeth C. Wayne et al.
ADVANCED SCIENCE (2019)
Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response
Mahnaz Sahraei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice
Lisa Munakata et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
F. Zhang et al.
NATURE COMMUNICATIONS (2019)
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
Zuzanna Urban-Wojciuk et al.
FRONTIERS IN IMMUNOLOGY (2019)
Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer
Manisit Das et al.
MOLECULAR THERAPY (2019)
A Phase I, open-label, multicenter, dose escalation study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36., for intratumoral injection alone and in combination with immune checkpoint blockade
Todd Bauer et al.
CANCER RESEARCH (2019)
Nanoemulsions and Their Potential Applications in Food Industry
Jamuna Bai Aswathanarayan et al.
FRONTIERS IN SUSTAINABLE FOOD SYSTEMS (2019)
Nanoparticles in the clinic: An update
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Hybrid nanovaccine for the co-delivery of the mRNA antigen and adjuvant
Jingnan Yang et al.
NANOSCALE (2019)
Delivery of a Modified mRNA Encoding IL-22 Binding Protein (IL-22BP) for Colon Cancer Gene Therapy
Rui Zhang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2018)
A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates
Staci Sabnis et al.
MOLECULAR THERAPY (2018)
Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
David R. Wilson et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
Colin J. McKinlay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Jonathan D. Finn et al.
CELL REPORTS (2018)
The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
Zijun Zhao et al.
ACTA PHARMACEUTICA SINICA B (2018)
Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune response
Hirotaka Imai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers
David L. Elion et al.
CANCER RESEARCH (2018)
An RNA toolbox for cancer immunotherapy
Fernando Pastor et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
Ruchi Jain et al.
NUCLEIC ACID THERAPEUTICS (2018)
Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies
Toshiki Iwai et al.
Oncotarget (2018)
The suppressive effect of co-inhibiting PD-1 and CTLA-4 expression on H22 hepatomas in mice
Leilei Liang et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2018)
Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
Ian Lai et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer
Ning Cheng et al.
JCI INSIGHT (2018)
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Matthias A. Oberli et al.
NANO LETTERS (2017)
Effect of TLR ligands co-encapsulated with multiepitopic antigen in nanoliposomes targeted to human DCs via Fc receptor for cancer vaccines
Felix Rueda et al.
IMMUNOBIOLOGY (2017)
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA
Rein Verbeke et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers
Elizabeth L. Siegler et al.
MOLECULAR THERAPY (2017)
Lipid Nanoparticle Systems for Enabling Gene Therapies
Pieter R. Cullis et al.
MOLECULAR THERAPY (2017)
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
James E. Dahlman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Suvasini Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
Xi Zhu et al.
THERANOSTICS (2017)
Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
Jane Cullis et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Liposomal Formulations in Clinical Use: An Updated Review
Upendra Bulbake et al.
PHARMACEUTICS (2017)
Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model
Taro Shimizu et al.
CANCER SCIENCE (2017)
Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts
Jessica Hartmann et al.
EMBO MOLECULAR MEDICINE (2017)
Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy
Sandeep T. Koshy et al.
ADVANCED BIOSYSTEMS (2017)
A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression
Sisi Ma et al.
ONCOTARGET (2016)
Super natural killer cells that target metastases in the tumor draining lymph nodes
Siddarth Chandrasekaran et al.
BIOMATERIALS (2016)
Toxicities of chimeric antigen receptor T cells: recognition and management
Jennifer N. Brudno et al.
BLOOD (2016)
Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response
Arup Garu et al.
MOLECULAR THERAPY (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Opposing effects of alcohol on the immune system
Tasha Barr et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Jin Peng et al.
CANCER RESEARCH (2015)
The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor- receptor on dendritic cells potentiates tumour antigen-specific CD8+ T cell immunity
Y. -H. Ahn et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma
Hidetaka Akita et al.
JOURNAL OF CONTROLLED RELEASE (2015)
An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo
Bin Li et al.
NANO LETTERS (2015)
Immune activation by medium-chain triglyceride-containing lipid emulsions is not modulated by n-3 lipids or toll-like receptor 4
Evelyn D. Olthof et al.
TOXICOLOGY IN VITRO (2015)
Killing cancer cells using nanotechnology: novel poly(I:C) loaded liposome-silica hybrid nanoparticles
Valentina Colapicchioni et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity
Eleni Maria Varypataki et al.
AAPS JOURNAL (2015)
Nanoemulsion: an advanced mode of drug delivery system
Manjit Jaiswal et al.
3 BIOTECH (2015)
Lipid antigens in immunity
C. Marie Dowds et al.
BIOLOGICAL CHEMISTRY (2014)
Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
Darya Alizadeh et al.
CANCER RESEARCH (2014)
Innate immune pathways in afferent lymph following vaccination with poly(I:C)-containing liposomes
Melissa L. Burke et al.
INNATE IMMUNITY (2014)
A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy
Hiroko Miyabe et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Targeted siRNA Silencing of Indoleamine 2, 3-Dioxygenase in Antigen-presenting Cells Using Mannose- conjugated Liposomes: A Novel Strategy for Treatment of Melanoma
Di Chen et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Combinational Delivery of Hydrophobic and Hydrophilic Anticancer Drugs in Single Nanoemulsions To Treat MDR in Cancer
Yan Ma et al.
MOLECULAR PHARMACEUTICS (2014)
Attenuated A20 expression of acute myeloid leukemia-derived dendritic cells increased the anti-leukemia immune response of autologous cytolytic T cells
Xioying Zhang et al.
LEUKEMIA RESEARCH (2014)
MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene
J. Yang et al.
ONCOGENE (2014)
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Yizhou Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Paula Codo et al.
ONCOTARGET (2014)
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation
Willemijn Hobo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Developing Lipid Nanoparticle-Based siRNA Therapeutics for Hepatocellular Carcinoma Using an Integrated Approach
Leiming Li et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
Martin A. Maier et al.
MOLECULAR THERAPY (2013)
miR-126 and miR-126*repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis
Yun Zhang et al.
NATURE CELL BIOLOGY (2013)
Nanoemulsions: increasing possibilities in drug delivery
Kumar Bishwajit Sutradhar et al.
EUROPEAN JOURNAL OF NANOMEDICINE (2013)
Immunological effects of Taxol and Adryamicin in breast cancer patients
C. Panis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells
Helen Conroy et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions
K. Iwamura et al.
GENE THERAPY (2012)
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
Hsin-I Chang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner
Tillmann Michels et al.
JOURNAL OF IMMUNOTOXICOLOGY (2012)
The effect of neutral helper lipids on the structure of cationic lipid monolayers
A. P. Dabkowska et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2012)
Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma Patients
An M. T. Van Nuffel et al.
MOLECULAR THERAPY (2012)
Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells
Shan Wan et al.
PLOS ONE (2012)
A20 Silencing by Lipid Envelope-Type Nanoparticles Enhances the Efficiency of Lipopolysaccharide-Activated Dendritic Cells
Shota Warashina et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
Kristin A. D. Sauter et al.
CANCER BIOLOGY & THERAPY (2011)
Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
Michelle Hong et al.
CANCER RESEARCH (2011)
Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer
Tzu-Ting Huang et al.
CANCER SCIENCE (2011)
Mifamurtide for the treatment of nonmetastatic osteosarcoma
Kosei Ando et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy
Yuting Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor Immunity
Zuqiang Liu et al.
JOURNAL OF IMMUNOLOGY (2011)
Edible nanoemulsions: fabrication, properties, and functional performance
David Julian McClements
SOFT MATTER (2011)
STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo
Aws Alshamsan et al.
TRANSLATIONAL ONCOLOGY (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Lentiviral-mediated Foxp3 RNAi suppresses tumor growth of regulatory T cell-like leukemia in a murine tumor model
B-Y Tsai et al.
GENE THERAPY (2010)
Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets
Shijun Kang et al.
IMMUNOBIOLOGY (2010)
Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation
Hidetaka Akita et al.
JOURNAL OF CONTROLLED RELEASE (2010)
STAT3 Silencing in Dendritic Cells by siRNA Polyplexes Encapsulated in PLGA Nanoparticles for the Modulation of Anticancer Immune Response
Aws Alshamsan et al.
MOLECULAR PHARMACEUTICS (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Lipid-like materials for low-dose, in vivo gene silencing
Kevin T. Love et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mitoxantrone-Mediated Apoptotic B16-F1 Cells Induce Specific Anti-tumor Immune Response
Chunyu Cao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity
Juan R. Cubillos-Ruiz et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine
Kaley D. Wilsonl et al.
JOURNAL OF GENE MEDICINE (2009)
MBP-426, a novel liposome-encapsulated oxaliplatin, in combination with 5-FU/leucovorin (LV): Phase I results of a Phase I/Il study in gastro-esophageal adenocarcinoma, with pharmacokinetics
Neil N. Senzer et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy
Lei Zhang et al.
CLINICAL IMMUNOLOGY (2008)
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
Noam Stern-Ginossar et al.
NATURE IMMUNOLOGY (2008)
A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression
Xiao-Tong Song et al.
NATURE MEDICINE (2008)
Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts
William C. Zamboni et al.
CLINICAL CANCER RESEARCH (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag
Nada M. Melhem et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Cubic phases in phosphatidylcholine-cholesterol mixtures: Cholesterol as membrane fusogen''
Boris G. Tenchov et al.
BIOPHYSICAL JOURNAL (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression
E Ambegia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model
Y Eralp et al.
BREAST CANCER RESEARCH (2004)
OSI-211, a novel liposomal topoisomerase I inhibitor, is active in SCID mouse models of human AML and ALL
B Tomkinson et al.
LEUKEMIA RESEARCH (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes
LY Song et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2002)
Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system
F Sakurai et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2001)
Roles of lipid polymorphism in intracellular delivery
IM Hafez et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures
SC Semple et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
分享论文
